ABRAMS CAPITAL MANAGEMENT, L.P.

Holdings History for TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)

Symbol: TEVA on NYSE
Investment type: Equity / Ordinary Shares, par value NIS 0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2024		-1.9%	$0	0	-5,996,836	-100%	$34.80	Q1 2024
31 Dec 2023	1.9%	-0.64%	$62,606,968	5,996,836	-1,969,597	-25%	$10.44	Q4 2023
30 Sep 2023	2.7%	0%	$81,257,617	7,966,433	0		$10.20	Q3 2023
30 Jun 2023	1.7%	0%	$59,987,240	7,966,433	0		$7.53	Q2 2023
31 Mar 2023	2.2%	-2.2%	$70,502,932	7,966,433	-7,966,432	-50%	$8.85	Q1 2023
31 Dec 2022	5.2%	-2.6%	$145,307,729	15,932,865	-7,966,431	-33%	$9.12	Q4 2022
30 Sep 2022	5.6%	-0.03%	$192,867,000	23,899,296	-147,060	-0.61%	$8.07	Q3 2022
30 Jun 2022	4.9%	0%	$180,829,000	24,046,356	0		$7.52	Q2 2022
31 Mar 2022	5.3%	0%	$225,795,000	24,046,356	0		$9.39	Q1 2022
31 Dec 2021	4.2%	0%	$192,611,000	24,046,356	0		$8.01	Q4 2021
30 Sep 2021	5.1%	0%	$234,212,000	24,046,356	0		$9.74	Q3 2021
30 Jun 2021	5.3%	0%	$238,059,000	24,046,356	0		$9.90	Q2 2021
31 Mar 2021	6.2%	0%	$277,495,000	24,046,356	0		$11.54	Q1 2021
31 Dec 2020	6.6%	0%	$232,047,000	24,046,356	0		$9.65	Q4 2020
30 Sep 2020	6.8%	0%	$216,658,000	24,046,356	0		$9.01	Q3 2020
30 Jun 2020	9.6%	0%	$296,492,000	24,046,356	0		$12.33	Q2 2020
31 Mar 2020	8.5%	0%	$215,936,000	24,046,356	0		$8.98	Q1 2020
31 Dec 2019	7.3%	0%	$235,654,000	24,046,356	0		$9.80	Q4 2019
30 Sep 2019	4.6%	+1.2%	$165,439,000	24,046,356	+6,000,000	+33%	$6.88	Q3 2019
30 Jun 2019	4.5%	0%	$166,568,000	18,046,356	0		$9.23	Q2 2019
31 Mar 2019	7.9%	-0.21%	$282,967,000	18,046,356	-476,016	-2.6%	$15.68	Q1 2019
31 Dec 2018	12%	-0.64%	$285,615,000	18,522,372	-1,000,000	-5.1%	$15.42	Q4 2018
30 Sep 2018	11%	-0.13%	$420,512,000	19,522,372	-220,751	-1.1%	$21.54	Q3 2018
30 Jun 2018	13%	0%	$480,153,000	19,743,123	0		$24.32	Q2 2018
31 Mar 2018	11%	0%	$337,410,000	19,743,123	0		$17.09	Q1 2018
31 Dec 2017	13%	-1.2%	$374,132,000	19,743,123	-1,880,763	-8.7%	$18.95	Q4 2017
30 Sep 2017	15%	+15%	$380,580,000	21,623,886	+21,623,886	NEW	$17.60	Q3 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.